The First Commercial Contract

How we underwrite a venture’s market hypothesis, and why the first $50K of revenue tells you more than the next $500K.

Why this matters more than any deck

Every venture investment is, at heart, a bet on a market hypothesis: there is a customer, with a problem, who will pay a specific price, with a specific frequency, to a vendor that meets a specific bar. Pre-revenue, this hypothesis is a story. The first commercial contract is the moment the story becomes data.

We have come to treat the first contract (the actual signed agreement, with money flowing, for a product in production use) as the single most important diagnostic event in a company’s first 24 months. It does more work in our underwriting than any market research, any expert interviews, any analyst report, and frequently more work than the next ten contracts combined. The reason is that the first contract is the only piece of evidence in which all five elements of the company (people, technology, investment, strategy, market) meet a customer who has no incentive to be polite.

What we actually read from the first contract

A first contract has six diagnostic dimensions. We read each of them carefully. None of them is the headline number. The contract value itself is the least informative thing about it.

Who signed, and at what level

If the signatory is the operational sponsor (the person whose team will use the product), the company has solved a real but local problem. If the signatory is the budget owner, the company has solved a problem the customer will fund. If the signatory is the executive (C-suite or one level down), the company has solved a problem the customer considers strategic. The progression matters. A first contract signed by an operational sponsor with a $40K budget is a different commercial validation than the same contract signed by a CFO out of a strategic line.

Time-to-signature

Velocity of close, measured from first qualified conversation to signed agreement, is the single best leading indicator of commercial trajectory in our experience. A first contract that closes in under 90 days from first qualified meeting tells us the buyer’s urgency is real. A first contract that closes in 9 months tells us the buyer was educated into the urgency, which means every subsequent contract will require that same education cycle. The first kind compounds. The second kind grinds.

What got cut from the original scope

Every first contract is smaller in scope than the company originally proposed. The reduction is diagnostic. If what got cut is roadmap features (“we’ll add the analytics later”), the customer agrees with the core thesis and is buying it. If what got cut is the core thesis (“we just want the data pipeline, skip the analytics”), the customer is buying the company’s most commoditized capability and the differentiator did not survive procurement. Read this carefully. Many first contracts that founders celebrate are quiet rejections of the actual thesis.

How procurement handled it

The friction the contract encountered through procurement is information. A first contract that closes on standard vendor terms without serious back-and-forth means the customer has bought from companies of this profile before, which is good (validation) and bad (commodity). A first contract that takes 12 weeks in legal, generates a 40-line MSA, requires a security review, an InfoSec review, and a business-continuity attestation means the customer is treating you as a new category, which is bad (sales-cycle reality) and good (defensible).

How the customer paid

Payment terms are an underwriting signal. A customer paying upfront (annually, in advance) is treating you as strategic and is willing to invest in the relationship’s success. A customer pushing for monthly billing and 60-day net terms is treating you as a discretionary line item. A customer requiring milestone-based payments tied to specific deliverables is treating you as a project, not a product. None of these are right or wrong, but each one tells you what kind of company you are building, regardless of what you intended to build.

What happened in the 90 days after signature

This is the diagnostic that matters most and the one most founders fail to track rigorously. In the 90 days after the first contract is signed, three things happen, or they don’t. The product gets deployed to production. The customer’s team actually uses it (measured in active users, not in seats sold). The customer’s sponsor introduces you to a peer at another company without being asked. If all three happen, the thesis is real and the company has a business. If only the first two happen, the company has a product. If only the first happens, the company has sold a piece of paper.

How we use this in underwriting

When we are evaluating a build to take from concept, we model the first commercial contract in advance: the named target customer, the named signatory, the time-to-close estimate, the price band, the procurement-friction profile, the post-signature 90-day expectations. We then track against the model from week one of the build. Companies whose first contract substantially matches the modeled profile are companies whose subsequent contracts compound. Companies whose first contract surprises us, even pleasantly, are companies whose subsequent commercial behavior we cannot predict, which means the underlying market is doing something we do not yet understand.

This is not a fail-fast philosophy. It is a fail-precisely philosophy. The point of the first contract is to learn whether the thesis is correct. A thesis that is partially correct produces a partially correct first contract, and the partial correctness (which part of the scope survived procurement, which part got cut) tells us how to revise the build. Companies that revise from a first-contract signal are companies that scale. Companies that try to power through a first-contract signal that disagrees with their thesis are companies that build the wrong machine very efficiently.

A note on pricing the first contract

Founders consistently price the first contract too low. The instinct is understandable: lower price, faster close, social proof on the website. The cost is not visible until the second and third contract, when the company discovers that the pricing precedent it set with customer one is now anchoring every subsequent negotiation.

Our default rule: the first commercial contract should be priced at a 30 to 50 percent discount to the company’s intended steady-state price, in exchange for explicit case-study rights, a named reference customer, and a structured price step-up at renewal. Below 30 percent discount and the customer feels they overpaid for being a pioneer. Above 50 percent discount and the company has made the contract its product, which means every future deal becomes a negotiation against this anchor.

Founders should also avoid the inverse mistake, pricing the first contract too high in the belief that it sets a premium anchor. It rarely does. The procurement team in the second deal will discover the first deal’s price through a reference check, a former employee, or a competitor’s intelligence. The honest discount, openly framed as a pilot price with a structured step-up, costs nothing and protects the price curve.

Closing

The first commercial contract is not a milestone to be celebrated. It is a diagnostic instrument that, if read carefully, tells the company more about what to build next than any other piece of evidence available to it. The companies in our portfolio that read this signal precisely are the ones that compound. The ones that do not, do not.
Element-5’s role in this, distinct from a typical investor, is to be in the room for the first contract. We help model it, structure it, negotiate it, and read it. The signal it produces shapes everything that comes after.

ABOUT THE FIRM

Element-5 Capital is a technology-driven venture builder headquartered in Charlotte, NC. We partner with founders to commercialize high-conviction ideas, engineering the people, technology, investment, strategy, and market that move a company from concept to outcome. We engage from concept through Series B, across the build-to-scale arc.

Want to discuss this with us? Founders should write to founders@element-5.com. Limited partners and family offices, lp@element-5.com. For press, press@element-5.com.